FY2025 Earnings Estimate for TSE:MDP Issued By Stifel Canada
Analysts at Stifel Canada raised their FY2025 earnings estimates for Medexus Pharmaceuticals in a research note issued to ...
Medexus Pharmaceuticals (TSE:MDP) Price Target Raised to C$4.50
Medexus Pharmaceuticals (TSE:MDP – Free Report) had its price objective increased by Stifel Nicolaus from C$4.15 to C$4.50 in a research report released on Tuesday morning,BayStreet.CA reports.